Advertisement
Screener

SUTRO BIOPHARMA, INC. (STRO) Deferred Rent Credit, Noncurrent

SUTRO BIOPHARMA, INC. Deferred Rent Credit, Noncurrent

SUTRO BIOPHARMA, INC. (STRO) had Deferred Rent Credit, Noncurrent of $3.43 million as of 2021-06-30, per its 10-Q filed 2021-08-09.

Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent

us-gaap:DeferredRentCreditNoncurrent · last filed 2022-02-28

  • 2021-06-30: Deferred Rent Credit, Noncurrent $3.43M.
  • 2021-03-31: Deferred Rent Credit, Noncurrent $2.39M.
  • 2020-12-31: Deferred Rent Credit, Noncurrent $1.34M.
  • 2020-09-30: Deferred Rent Credit, Noncurrent $280.00K.
Period endDeferred Rent Credit, Noncurrent
2021-06-30$3.43M
10-Q · filed 2021-08-09
2021-03-31$2.39M
10-Q · filed 2021-05-07
2020-12-31$1.34M
10-K · filed 2022-02-28
2020-09-30$280.00K
10-Q · filed 2020-11-05
2020-06-30$330.00K
10-Q · filed 2020-08-06
2020-03-31$373.00K
10-Q · filed 2020-05-11
2019-12-31$409.00K
10-K · filed 2021-03-18
2019-09-30$435.00K
10-Q · filed 2019-11-08
2019-06-30$456.00K
10-Q · filed 2019-08-14
2019-03-31$469.00K
10-Q · filed 2019-05-15
2018-12-31$476.00K
10-K · filed 2020-03-16
2018-09-30$473.00K
10-Q · filed 2018-11-14
2017-12-31$428.00K
10-K · filed 2019-04-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Invivyd, Inc. (IVVD)United States$0.270B-2.42
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Liminatus Pharma, Inc. (LIMN)United States$0.282B
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87